Department of Physiology and Cell Biology (L.E.D., F.A.), Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus.
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel (L.L., J.H.H.).
Circulation. 2019 Jan 22;139(4):533-545. doi: 10.1161/CIRCULATIONAHA.118.036146.
N-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known.
To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function.
We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis.
Our study identified METTL3-mediated methylation of mRNA on N-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.
N6-甲基腺苷(m6A)甲基化是哺乳动物 mRNA 上最普遍的内部转录后修饰。m6A mRNA 甲基化在心脏中的作用尚不清楚。
为了确定 m6A 甲基化在心脏中的作用,我们分离了原代心肌细胞,并进行了 m6A 免疫沉淀,随后进行了 RNA 测序。然后,我们通过操纵 RNA 甲基转移酶样蛋白 3(METTL3)的水平,在培养物中和体内生成了遗传工具,以调节心肌细胞中的 m6A 水平。我们生成了心脏特异性的增益和缺失功能的小鼠模型,以允许评估 METTL3-m6A 通路在心脏稳态和功能中的作用。
我们测量了心肌细胞 mRNA 上的 m6A 甲基化水平,发现其在受到肥大刺激时显著增加,这表明 m6A 甲基化在心肌细胞肥大的发展中可能具有潜在的作用。m6A 甲基化分析显示,在调节激酶和细胞内信号通路的基因中存在显著富集。当刺激心肌细胞生长时,METTL3 的抑制完全阻断了心肌细胞肥大的能力,而 METTL3 的 m6A RNA 甲基转移酶的表达增加足以促进心肌细胞在体外和体内的肥大。最后,心脏特异性 METTL3 敲除小鼠在衰老和应激时表现出心力衰竭的形态和功能迹象,这表明 RNA 甲基化对于维持心脏稳态是必要的。
我们的研究确定了 METTL3 介导的 mRNA 上的 N-腺苷的甲基化作为一种动态修饰,它在受到肥大刺激时增强,并且是心肌细胞中正常肥大反应所必需的。增强的 m6A RNA 甲基化导致代偿性心肌肥大,而减少的 m6A 导致偏心性心肌细胞重塑和功能障碍,这突出了这种新的应激反应机制在心脏中对维持正常心脏功能的至关重要性。